Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma

NCT00089219 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Intraocular Melanoma
Melanoma (Skin)

Interventions

BIOLOGICAL: IFA
BIOLOGICAL: 6MHP
BIOLOGICAL: GM-CSF

Sponsor

University of Virginia

Collaborators

[object Object]